• Consultation on scientific merits of novel molecules and devices

• Planning pathways for drug and device registration

• Problem solving during various stage of development

We Provide services to sponsors, other CROs, or sites:

​

• Contract

• IRB submission

• Patient recruitment and follow up

• Adverse events reporting

• Ensuring protocol compliance

• Patient recruitment support

• Principal Investigator support

• Expansive network of patients with database of 20,000+ Chinese patients for rapid recruitment in Hong Kong

• Validated methods of recruitment by electronic media

• Community outreach activities with 100+ community organizations

• Dedicated clinical trials clinic

• Conduct of trials in-house, from patient recruitment, screening, randomization, follow-up, eCRF entry, AE and SAE assessment, preparation and attendance in audits, to drug registration.

• Scientific advice design of phase 2,3, and 4 trials

• Our team advises on the most up-to-date regulatory and ethic requirements in China and Hong Kong to ensure that all trials are compliant with local legislation and regulations.

• Strong experience with global regulatory authority audits including FDA (USA), NMPA (China) and EMEA (European Union) leading to trial drugs registered globally.

• Dedicated QA and QC team

• Real-time response to queries by investigators and coordinators.